anti-CD19 CAR T cells

1 Drug classified under this active ingredient

Advanced Therapy. anti-CD19 CAR T cells 0.4 – 2 × 10^8 cells.
0.4 – 2 × 10⁸ cells dispersion for IV. Autolog. use only. Single dose 2 × 10⁶ /kg b.w. in approx. 68 mL dispers. in an infus. bag. Recommen. to be infus. 3 to 14 days. Aft. complet.  lymphodeplet. chemother. See lit.
Tmt. adult pts. with relapse. or refract. mantle cell lymphoma after 2 or more lines of sys. ther. incl. Bruton's tyrosine kinase (BTK) inhib. unless inelig. to BTK inhib. Not indicat. for tmt. pts. with active CNS lymphoma.
C/I: hypresens. see lit.